CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Guangdong Zhongsheng Pharmaceutical Co Ltd Company Snapshot
Guangdong Zhongsheng Pharmaceutical Co Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Guangdong Zhongsheng Pharmaceutical Co Ltd with three other companies in this sector in China: Guangxi Wuzhou Zhongheng Group, Ltd. (2016 sales of 1.67 billion Chinese Renmimbi [US$252.33 million] of which 94% was Pharmaceutical Segment), Shanghai Shenqi Pharmaceutical Investment Management CoLtd (1.60 billion Chinese Renmimbi [US$241.49 million] of which 83% was Pharmaceutical), and Jiang Zhong Pharmaceutical Co Ltd (1.56 billion Chinese Renmimbi [US$235.99 million] of which 100% was Medical Industry).

Sales Analysis. During the year ended December of 2016, sales at Guangdong Zhongsheng Pharmaceutical Co Ltd were 1.69 billion Chinese Renmimbi (US$255.77 million). This is an increase of 7.3% versus 2015, when the company's sales were 1.58 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Guangdong Zhongsheng Pharmaceutical Co Ltd (and since 2011, sales have increased a total of 125%). Sales of Medicine Trading saw an increase that was more than double the company's growth rate: sales were up 110.9% in 2016, from 35.66 million Chinese Renmimbi to 75.20 million Chinese Renmimbi. Guangdong Zhongsheng Pharmaceutical Co Ltd also saw significant increases in sales in Other (up 68.0% to 44.24 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Guangdong Zhongsheng Pharmaceutical Co Ltd
  Stock Performance Chart for Guangdong Zhongsheng Pharmaceutical Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (12/15/2017): 12.61
(Figures in Chinese Renmimbi)
1 Week 1.0%   13 Weeks 5.2%  
4 Weeks 5.5%   52 Weeks 2.1%  
 
Guangdong Zhongsheng Pharmaceutical Co Ltd Key Data:
  Ticker: 002317 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 1,692,412,396
(Year Ending Jan 2017).
Employees: 1,833
  Currency: Chinese Renmimbi Market Cap: 10,270,354,168
  Fiscal Yr Ends: December Shares Outstanding: 814,461,076
  Share Type: Gu Closely Held Shares: 368,271,180
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.